Typical Savings with Yervoy Discounts
Patients using manufacturer coupons or copay cards for Yervoy (ipilimumab) often pay as little as $10–$25 per infusion or monthly dose, regardless of insurance, saving thousands compared to out-of-pocket costs. Without discounts, copays or coinsurance can exceed $5,000–$10,000 per cycle for commercially insured patients, based on a list price around $32,000 per 4-week cycle (10 mg/kg dose).[1][2]
Who Qualifies for Bristol Myers Squibb's Copay Program
BMS Access Support covers Yervoy copays for patients with commercial insurance (not government plans like Medicare). Eligibility requires household income verification in some cases; savings cap at $25,000 annually per patient. Uninsured patients may get free drug through patient assistance programs if income is under 500% of federal poverty level.[1][3]
Average Savings by Insurance Type
- Commercial insurance: Discounts reduce average copay from $4,500+ to $5–$25 per dose; one study found 70% of users pay $0 after assistance.[2][4]
- Medicare: No copay cards allowed, but Extra Help or low-income subsidies cut costs by 50–100% (e.g., from $10,000+ deductible to $0–$1,000/year).[3]
- Uninsured: Full cost $30,000+/cycle drops to $0 via BMS patient assistance for qualifiers.[1]
Real-world data from 2023 shows eligible patients saved $15,000–$20,000 annually on average.[4]
How to Get Yervoy Discounts and Cards
Apply via BMS Access at 1-888-847-4877 or bmsaccesssupport.com. Instant copay cards activate at pharmacies/infusion centers. GoodRx or SingleCare coupons offer 5–10% off cash price (less effective for infusions).[1][5] Pharmacy benefit managers like Express Scripts add further rebates.
Limits and What If You Don't Qualify
Programs exclude 90-day supply limits or end after 12–48 months. Non-qualifiers turn to state assistance, 340B hospitals (30–50% discounts), or generics (none available yet).[3] Patent protection lasts until at least 2028, delaying biosimilars.[6]
Yervoy vs. Other Immunotherapy Discounts
Yervoy savings mirror Opdivo (same maker), with similar $0–$25 copays. Keytruda cards cap at $17,000/year. Patients switching therapies often save more with biosimilars like bevacizumab (60–80% cheaper than branded Avastin).[2][4]
[1]: BMS Access Support
[2]: GoodRx Yervoy Pricing
[3]: NeedyMeds Yervoy Assistance
[4]: Health Affairs Study on Oncology Copay Assistance (2023)
[5]: SingleCare Yervoy Coupons
[6]: DrugPatentWatch Yervoy Patents